Postpartum Opioid Prescribing and Persistent Use in Western Countries

Jashvant Poeran,Chang H. Park

DOI: https://doi.org/10.1213/ane.0000000000006953

IF: 6.627

2024-04-17

Anesthesia & Analgesia

Abstract:See Article, page 970 A large majority of women experiencing childbirth rate their pain as severe 1 with a significant proportion reporting persistent pain: up to 20% with scar pain after cesarean delivery and perineal or vaginal pain in up to 6% at 6 months after birth. 2 Consequently, prescription of opioids is not uncommon in the postpartum period; however, concerns exist regarding their persistent use, typically estimated at a rate of <2% of those exposed to opioids, depending on the study setting. 3 With 3.6 4 and 4.1 million 5 annual births in the United States and European Union, respectively, these numbers translate to a significant burden on the population level in Western countries. Identifying who will be at risk of persistent opioid use after exposure in the postpartum period is an obvious first step to mitigate this burden. However, opioid use patterns––and thus risk of persistent use––vary greatly between countries, necessitating setting-specific risk factor analyses. 6 It is in this context that the study by Varney et al 7 provides an important addition to the current literature by providing data from Australia in addition to already existing prevalence estimates and risk factor analyses from the United States, 8 Denmark, 9 and Canada. 3 Studying 38,832 women who were dispensed an opioid in the 14 days after discharge after childbirth (over a total of 556,020 women discharged after childbirth) they describe an increasing trend in postpartum opioid prescribing among women discharged after a cesarean delivery (from 9.8%–16.6% in 2012 to 19.5%–21.0% in 2018); no such trends were observed for women discharged after a vaginal birth, generally associated with much less opioid prescribing (1.2%–1.5% in 2012 to 1.4%–1.5% in 2018). Oxycodone (44.8%), codeine (42.1%), and tramadol (12.9%) were most often prescribed. The authors also describe a prevalence of persistent opioid use of 11.4% and 4.3% among women that were dispensed an opioid after a vaginal or cesarean delivery, respectively. Here, persistent opioid use was defined using a previously published definition 9 : having at least 3 opioid prescriptions filled at any time between 30 and 365 days postdischarge. Finally, Varney et al 7 assessed the association between a variety of characteristics and persistent opioid use, and interestingly report that their findings suggest that patient characteristics rather than events that occur at birth are important indicators of risk of persistent opioid use and that "the postpartum period may represent a period of vulnerability for patients with such predisposing conditions." Also notable was the link between persistent opioid use and affluency of a patient's residential area (lower risk in more affluent areas), rurality (higher risk in more remote areas), and hospital type (higher risk in public hospitals), suggesting substantial sources of variation in postpartum opioid prescribing. These findings highlight 3 core issues: the need for (1) continued monitoring across settings, (2) more guidance/standardization, and (3) thorough understanding of mechanisms behind postpartum prescription of opioids and subsequent persistent use.

anesthesiology